Inhibitors of the renin-angiotensin system have been shown to reduce cardiovascular events, decrease diabetic complications and can reduce incidence of new onset diabetes (Hansson et al., 1999; Heart Outcomes Prevention Evaluation Study, 2000; Brenner et al., 2001; Dahlof, 2002; Bangalore et al., 2011). This evidence concerns the gene REN and diabetes mellitus.